Phreesia, Inc.

PHR Healthcare Health Information Services

Phreesia, Inc.’s revenue for fiscal 2026 (year ended January 2026) was $480.6 million, up 14.5% from fiscal 2025. In the quarter to July 2026, revenue grew 10.4%, EPS grew 200.0%, free cash flow grew 43.5% and total debt rose 3,191.9%, each against the same quarter a year earlier. Revenue growth for five consecutive years, operating cash flow growth for three; insiders bought in the last twelve months.

10.94 0.10 −0.91%
Market cap
$685.3M
P/E
64.4×
Fwd P/E
23.5×
Dividend yield
—
F-score
5/9
Altman Z
0.65
Beneish M
−2.15
Dividend safety
n/a
Jul '26 Apr '26 Jan '26 Oct '25 Older periods
Piotroski F-Score
4 4 5 7

+8 more TTM periods

ROE
3.12% 2.86% 0.77% (1.87%)
ROA
1.98% 1.72% 0.44% (1.35%)
ROIC
1.74% 0.46% (0.94%) (2.49%)
Return on Tangible Assets
8.18% 6.77% 1.97% (3.30%)
Average Days of Receivables
96.52 105.54 117.44 69.55
Free Cash Flow per Share
1.09 1.04 0.91 0.58
Free Cash Flow
67.52 63.33 54.42 35.09
Capital Expenditures
(23.86) (24.55) (24.40) (26.32)
Other line items
Cash ROIC
11.34% 10.38% 9.28% 8.16%
Accounts Receivable Turnover
4.81 4.54 4.21 5.80
Accounts Payable Turnover
17.58 21.12 18.03 13.34
Inventory Turnover
0.00 0.00 0.00 0.00
Average Days of Payables
27.08 27.23 27.18 15.41
Days of Inventory on Hand
0.00 0.00 0.00 0.00
Tax Rate
2.78 (9.85) (1.26) 0.35
Research and Development Expense of Revenue
22.90% 23.81% 25.28% 25.95%
Selling, General and Administrative Expense of Revenue
34.84% 36.37% 37.48% 37.95%
Share Based Compensation of Revenue
11.70% 12.87% 14.04% 14.37%
Interest Coverage
1.19 0.37 (0.83) —
Operating CF/Net income
8.75 9.57 34.18 (11.42)
Depreciation/Fixed assets
2.26 1.87 1.72 1.39
Capex/Depreciation
(0.58) (0.64) (0.70) (0.89)
Revenue per Share
8.21 8.13 8.05 7.72
Operating CF per Share
1.48 1.44 1.32 1.02
Capex per Share
(0.39) (0.40) (0.41) (0.44)
Capex to Sales
0.05 0.05 0.05 0.06

Fold the line items

Columns are period end dates